Pregnancy: Fetal abnormalities have been reported to occur in the offspring of women who have taken estrogen/progestogen combinations in early pregnancy. Rule out pregnancy as soon as it is suspected.
Rule of pregnancy before treatment is begun. Because of the anti endrogenic action of the Lydia Clair, feminization of the male fetuses has occurred in animal studies and may possibly occur in humans.
Lactation: The use of estrogen/progestogen combinations during the period a mother is breast-feeding her infant may not be advisable. The hormonal components are excreted in breast milk and may reduce its quantity and quality. The long-term effects on the developing child are not known. This drug may cause fluid retention. Conditions such as epilepsy.